Home > Insider Trading > Filing (0001382963-17-000172)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1460702	Ritter Pharmaceuticals Inc	RTTR	Pharmaceutical Preparations (2834)	263474527

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1631671	J Andrew Ritter	Ritter Pharmaceuticals, Inc. 1880 Century Park East, #1000 Los Angeles CA 90067	President	No	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-03	187,500	$0.00	1,004,772	No	4	P	Indirect	By Stonehenge Partners LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Stonehenge Partners LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to Buy)	Acquisiton	2017-10-03	187,500	$0.00	187,500	$0.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
187,500	2017-10-03	2022-10-03	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,250	Direct

Footnotes

Stonehenge Partners LLC ("Stonehenge") purchased 187,500 Class A Units of the Issuer, consisting of 187,500 shares of common stock and warrants to purchase 187,500 shares of common stock, in the Issuer's October 2017 public offering at the public offering price of $0.40 per Class A Unit. The shares of common stock and warrants that are part of the Class A Units sold to Stonehenge in the public offering were immediately separable and were issued separately in the offering.
As a managing partner of Stonehenge, the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.